- Home
- CRVS vs SENEA Comparison
CRVS vs SENEA Comparison
Compare CRVS & SENEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVS | SENEA |
|---|---|---|
| Founded | 2014 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.0M | 710.1M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVS | SENEA |
|---|---|---|
| Price | $7.69 | $109.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 70.6K |
| Earning Date | 11-04-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.79 |
| EPS | N/A | ★ 8.61 |
| Revenue | N/A | ★ $1,606,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.84 |
| Revenue Growth | N/A | ★ 8.33 |
| 52 Week Low | $2.54 | $70.58 |
| 52 Week High | $9.60 | $129.03 |
Technical Indicators
Market Signals| Indicator | CRVS | SENEA |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 40.83 |
| Support Level | $7.28 | $109.01 |
| Resistance Level | $7.86 | $111.51 |
| Average True Range (ATR) | 0.42 | 2.39 |
| MACD | -0.07 | -0.13 |
| Stochastic Oscillator | 29.01 | 16.76 |
Price Performance
Historical ComparisonAbout CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.